Response‐based modification of CHOP chemotherapy for canine B‐cell lymphoma

Despite high initial response rates, a subset of dogs with B‐cell lymphoma responds less robustly to CHOP‐based chemotherapy and experiences shorter survival. One hundred and four dogs with nodal B‐cell lymphoma were treated with a response‐based CHOP (RBCHOP) protocol modified based on response to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Veterinary & comparative oncology 2021-09, Vol.19 (3), p.541-550
Hauptverfasser:	Benjamin, Sarah E., Sorenmo, Karin U., Krick, Erika L., Salah, Pascale, Walsh, Koranda A., Weinstein, Nicole M., Keuler, Nicholas S., Avery, Anne C., Atherton, Matthew J., Lenz, Jennifer A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cyclophosphamide - therapeutic use dog Dog Diseases - drug therapy Dogs doxorubicin Doxorubicin - therapeutic use lymphocytosis Lymphoma, B-Cell - drug therapy Lymphoma, B-Cell - veterinary multicentric nodal Prednisone - therapeutic use Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!